Belen Fernandez - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Belen Fernandez's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayBelen Fernandez
Verified
Opinion Columnist, Al Jazeera English
Beats
Darts , Football , Cricket , And Golf , Alongside Local Politics And National Breaking News
Stocks and shares, equitiesCRYPTO etcAnything not really securitization
Content
By Belen Fernandez| Iprofesional Verified iProfesional | Salud | Wegovy 18/04/2025 - 13:30hs Wegovy, el fármaco "de las estrellas", llegará a Argentina en el último cuatrimestre del año tras una larga espera. Hay una gran expectativa alrededor del medicamento de Novo Nordisk, ya que trae una mayor dosis de semaglutida (2,4 mg) que Ozempic (0,5 mg) y está diseñado específicamente para la pérdida de peso. Los especialistas prevén una demanda masiva.
By Belen Fernandez| Al Jazeera English Verified On Monday, April 14, six elite American women blasted off into space from west Texas on a self-piloting rocket ship developed by the space technology company Blue Origin, owned by bazillionaire Amazon founder Jeff Bezos.
By Belen Fernandez| Iprofesional Verified iProfesional | Salud | Wegovy 18/04/2025 - 13:30hs Wegovy, el fármaco "de las estrellas", llegará a Argentina en el último cuatrimestre del año tras una larga espera. Hay una gran expectativa alrededor del medicamento de Novo Nordisk, ya que trae una mayor dosis de semaglutida (2,4 mg) que Ozempic (0,5 mg) y está diseñado específicamente para la pérdida de peso. Los especialistas prevén una demanda masiva.
Company Info
Al Jazeera English
A leading investment company in UAE, with discreet investments in diversified sectors and markets including real estate, constructions, industrial, food, transportation, and concrete. We work together to share ideas, identify and address risks, build tools, and explore new investment opportunities.
'+971 4 280 6881
Founded: 1999